TrialBMJ open2017

The effect of empagliflozin on oxidative nucleic acid modifications in patients with type 2 diabetes: protocol for a randomised, double-blinded, placebo-controlled trial.

Emil List Larsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.